TY - JOUR
T1 - Prescription Drug Monitoring Program Use
T2 - National Dental PBRN Results
AU - McCauley, J. L.
AU - Gilbert, G. H.
AU - Cochran, D. L.
AU - Gordan, V. V.
AU - Leite, R. S.
AU - Fillingim, R. B.
AU - Brady, K. T.
N1 - Funding Information:
We are very grateful to the network?s regional coordinators who followed up with network practitioners to improve the response rate: Midwest Region?Tracy Shea, RDH, BSDH; Western Region?Stephanie Hodge, MA; Northeast Region?Christine O?Brien, RDH; South Atlantic Region?Hanna Knopf, BA, Deborah McEdward, RDH, BS, CCRP; South Central Region?Claudia Carcel?n, MPH, Shermetria Massingale, MPH, CHES, Ellen Sowell, BA; Southwest Region?Stephanie Reyes, BA, Meredith Buchberg, MPH, Colleen Dolan, MPH).
Funding Information:
This research was supported by the National Institute on Drug Abuse (grant K23-DA036566) and the National Institute of Dental and Craniofacial Research (grant U19-DE-22516). Opinions and assertions contained herein are those of the authors and are not to be construed as necessarily representing the views of the respective organizations or the National Institutes of Health. The informed consent of all human subjects who participated in this investigation was obtained after the nature of the procedures had been explained fully. An Internet site devoted to details about the nation’s network is located at http://NationalDentalPBRN.org. We are very grateful to the network’s regional coordinators who followed up with network practitioners to improve the response rate: Midwest Region—Tracy Shea, RDH, BSDH; Western Region— Stephanie Hodge, MA; Northeast Region—Christine O’Brien, RDH; South Atlantic Region—Hanna Knopf, BA, Deborah McEdward, RDH, BS, CCRP; South Central Region—Claudia Carcelén, MPH, Shermetria Massingale, MPH, CHES, Ellen Sowell, BA; Southwest Region—Stephanie Reyes, BA, Meredith Buchberg, MPH, Colleen Dolan, MPH). The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.
Publisher Copyright:
© International & American Associations for Dental Research 2018.
PY - 2019/4/1
Y1 - 2019/4/1
N2 - Introduction: The American Dental Association recommends that dentists use a prescription drug monitoring program (PDMP) prior to prescribing an opioid for acute pain management. Objective: The objective of this study was to examine dentists’ experiences using their state PDMP, as well as the impact that state-mandated registration policies, mandated use policies, and practice characteristics had on the frequency with which dentists used their PDMP. Methods: We conducted a web-based cross-sectional survey among practicing dentist members of the National Dental Practice-Based Research Network (n = 805). The survey assessed prescribing practices for pain management and implementation of risk mitigation strategies, including PDMP use. Survey data were linked with network Enrollment Questionnaire data to include practitioner demographics and practice characteristics. Results: Nearly half of respondents (n = 375, 46.6%) reported having never accessed a PDMP, with the most common reasons for nonaccess being lack of awareness (n = 214, 57.1%) and lack of knowledge regarding registration and use (n = 94, 25.1%). The majority of PDMP users reported the program to be very helpful (58.1%) or somewhat helpful (31.6%). Dentists reported that PDMP use most often did not change their intended prescribing behavior (40.2%), led them not to prescribe an opioid (33.5%), or led them to prescribe fewer opioid doses (25.5%). Presence of a mandated use policy was significantly associated with increased frequency of PDMP use across a variety of situations, including prior to 1) prescribing any opioid for pain management, 2) issuing refills, 3) prescribing to new patients, and 4) prescribing to patients deemed high risk. Conclusion: Findings suggest that the majority of dentists find PDMPs helpful in informing their opioid-prescribing practices. Whereas the existence of a state-mandated use policy is a consistent predictor of dentists’ PDMP use, outreach and education efforts may overcome key barriers to use identified in this study. Knowledge Transfer Statement: Findings from this national survey suggest that the majority of practicing dentists find PDMPs helpful in informing their opioid-prescribing practices; however, consistent PDMP use was not common. Whereas the existence of a state-mandated use policy is a consistent predictor of dentists’ PDMP use, outreach and education efforts may overcome key barriers to use identified in this study.
AB - Introduction: The American Dental Association recommends that dentists use a prescription drug monitoring program (PDMP) prior to prescribing an opioid for acute pain management. Objective: The objective of this study was to examine dentists’ experiences using their state PDMP, as well as the impact that state-mandated registration policies, mandated use policies, and practice characteristics had on the frequency with which dentists used their PDMP. Methods: We conducted a web-based cross-sectional survey among practicing dentist members of the National Dental Practice-Based Research Network (n = 805). The survey assessed prescribing practices for pain management and implementation of risk mitigation strategies, including PDMP use. Survey data were linked with network Enrollment Questionnaire data to include practitioner demographics and practice characteristics. Results: Nearly half of respondents (n = 375, 46.6%) reported having never accessed a PDMP, with the most common reasons for nonaccess being lack of awareness (n = 214, 57.1%) and lack of knowledge regarding registration and use (n = 94, 25.1%). The majority of PDMP users reported the program to be very helpful (58.1%) or somewhat helpful (31.6%). Dentists reported that PDMP use most often did not change their intended prescribing behavior (40.2%), led them not to prescribe an opioid (33.5%), or led them to prescribe fewer opioid doses (25.5%). Presence of a mandated use policy was significantly associated with increased frequency of PDMP use across a variety of situations, including prior to 1) prescribing any opioid for pain management, 2) issuing refills, 3) prescribing to new patients, and 4) prescribing to patients deemed high risk. Conclusion: Findings suggest that the majority of dentists find PDMPs helpful in informing their opioid-prescribing practices. Whereas the existence of a state-mandated use policy is a consistent predictor of dentists’ PDMP use, outreach and education efforts may overcome key barriers to use identified in this study. Knowledge Transfer Statement: Findings from this national survey suggest that the majority of practicing dentists find PDMPs helpful in informing their opioid-prescribing practices; however, consistent PDMP use was not common. Whereas the existence of a state-mandated use policy is a consistent predictor of dentists’ PDMP use, outreach and education efforts may overcome key barriers to use identified in this study.
KW - behavior and behavior mechanisms
KW - dentistry
KW - education
KW - prescription drug abuse
KW - substance abuse
KW - substance-related disorders
UR - http://www.scopus.com/inward/record.url?scp=85058496094&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85058496094&partnerID=8YFLogxK
U2 - 10.1177/2380084418808517
DO - 10.1177/2380084418808517
M3 - Article
C2 - 30931705
AN - SCOPUS:85058496094
VL - 4
SP - 178
EP - 186
JO - JDR Clinical and Translational Research
JF - JDR Clinical and Translational Research
SN - 2380-0844
IS - 2
ER -